We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » JANSSEN RECALLS 19,000 LEAKY TRANSDERMAL OPIATE PATCHES
Drug leakage from the edges of its transdermal patches has prompted Janssen Pharmaceuticals to issue a Class I recall on its Duragesic (fentanyl transdermal system) patches, the firm reported Feb. 17.